International Journal of Molecular Sciences · 2024 · 21 citations · 83 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyInflammationPreventive CardiologyAtherosclerosis PharmacotherapyAtherosclerotic Cardiovascular Disease PreventionCardiovascular DiseaseCardiovascular Disease PreventionChronic Kidney DiseaseLipid-lowering TherapyAnti-inflammatory ActivityAtherosclerosis Molecular MechanismsAtherosclerosis RiskAtherosclerotic Disease PreventionAtherosclerotic Plaque CharacterizationAtherosclerotic Plaque RuptureAtherosclerotic Risk ReductionLow Physical Activity
Atherosclerotic cardiovascular disease (ASCVD) stands as the leading cause of mortality worldwide. At its core lies a progressive process of atherosclerosis, influenced by multiple factors. Among them, lifestyle-related factors are highlighted, with inadequate diet being one of the foremost, alongside factors such as cigarette smoking, low physical activity, and sleep deprivation. Another substantial group of risk factors comprises comorbidities. Amongst others, conditions such as hypertension, diabetes mellitus (DM), chronic kidney disease (CKD), or familial hypercholesterolemia (FH) are included here. Extremely significant in the context of halting progression is counteracting the mentioned risk factors, including through treatment of the underlying disease. What is more, in recent years, there has been increasing attention paid to perceiving atherosclerosis as an inflammation-related disease. Consequently, efforts are directed towards exploring new anti-inflammatory medications to limit ASCVD progression. Simultaneously, research is underway to identify biomarkers capable of providing insights into the ongoing process of atherosclerotic plaque formation. The aim of this study is to provide a broader perspective on ASCVD, particularly focusing on its characteristics, traditional and novel treatment methods, and biomarkers that can facilitate its early detection.
83
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text
European Society of Cardiology: cardiovascular disease statistics 2021
Adam Timmis, Panos Vardas, Nick Townsend et al. · European Heart Journal · 2021 · 1.1K citations · Full text